Matches in SemOpenAlex for { <https://semopenalex.org/work/W3038438777> ?p ?o ?g. }
- W3038438777 endingPage "566" @default.
- W3038438777 startingPage "560" @default.
- W3038438777 abstract "Bone metastases can cause high morbidity and mortality, often developing as they advance, especially in patients with prostate and breast cancers. Most drugs are rarely distributed to the bone and are hence pharmacologically ineffective in treating bone metastases. The development of drug targeting technologies is required for the efficient treatment of bone metastases. To date, numerous bone-targeting ligands, including tetracyclines, bisphosphonates, aspartic acid, and aptamers have been developed and used for bone-targeted delivery of anti-tumor drugs, peptide/protein drugs, nucleic acid drugs, and diagnostic imaging agents. The conjugates of drugs with bone-targeting ligands were first developed in the field of bone drug targeting systems; macromolecular carriers and nanoparticles modified with these bone-targeting ligands have also been developed. Additionally, antibodies to prostate-specific membrane antigen (PSMA) and human epidermal growth factor receptor 2 (HER2) are used in active targeting bone metastatic prostate cancer and breast cancer, respectively. Some conjugates using antibodies to PSMA and HER2 were developed and used in clinical trials. In this review, recent challenges in the development of bone-targeted delivery systems and strategies for the treatment of bone metastasis have been summarized. Future development of novel drug formulations in order to optimize targeted drug delivery in the treatment of bone metastasis have also been discussed." @default.
- W3038438777 created "2020-07-10" @default.
- W3038438777 creator A5019544664 @default.
- W3038438777 creator A5036000781 @default.
- W3038438777 creator A5060619493 @default.
- W3038438777 creator A5069866009 @default.
- W3038438777 date "2020-07-01" @default.
- W3038438777 modified "2023-10-15" @default.
- W3038438777 title "Bone-Targeted Drug Delivery Systems and Strategies for Treatment of Bone Metastasis" @default.
- W3038438777 cites W1174216231 @default.
- W3038438777 cites W1560691946 @default.
- W3038438777 cites W1602052748 @default.
- W3038438777 cites W1907272683 @default.
- W3038438777 cites W1986448070 @default.
- W3038438777 cites W1997274211 @default.
- W3038438777 cites W2001014653 @default.
- W3038438777 cites W2002516695 @default.
- W3038438777 cites W2004799062 @default.
- W3038438777 cites W2010823062 @default.
- W3038438777 cites W2011350479 @default.
- W3038438777 cites W2013218984 @default.
- W3038438777 cites W2023823401 @default.
- W3038438777 cites W2025672294 @default.
- W3038438777 cites W2035185226 @default.
- W3038438777 cites W2035755166 @default.
- W3038438777 cites W2037992064 @default.
- W3038438777 cites W2040576725 @default.
- W3038438777 cites W2043074430 @default.
- W3038438777 cites W2047103966 @default.
- W3038438777 cites W2048709002 @default.
- W3038438777 cites W2063147677 @default.
- W3038438777 cites W2063185156 @default.
- W3038438777 cites W2075939968 @default.
- W3038438777 cites W2081588688 @default.
- W3038438777 cites W2086035454 @default.
- W3038438777 cites W2089220360 @default.
- W3038438777 cites W2089267373 @default.
- W3038438777 cites W2089480064 @default.
- W3038438777 cites W2092230369 @default.
- W3038438777 cites W2106875582 @default.
- W3038438777 cites W2112638371 @default.
- W3038438777 cites W2113701976 @default.
- W3038438777 cites W2122767481 @default.
- W3038438777 cites W2129442897 @default.
- W3038438777 cites W2131712774 @default.
- W3038438777 cites W2133826136 @default.
- W3038438777 cites W2135892944 @default.
- W3038438777 cites W2170309090 @default.
- W3038438777 cites W2170744486 @default.
- W3038438777 cites W2277879584 @default.
- W3038438777 cites W2303964045 @default.
- W3038438777 cites W2312914396 @default.
- W3038438777 cites W2337572018 @default.
- W3038438777 cites W2338741450 @default.
- W3038438777 cites W2379874806 @default.
- W3038438777 cites W2410508711 @default.
- W3038438777 cites W2462379302 @default.
- W3038438777 cites W2524354109 @default.
- W3038438777 cites W2570509606 @default.
- W3038438777 cites W2735592130 @default.
- W3038438777 cites W2766964027 @default.
- W3038438777 cites W2792288107 @default.
- W3038438777 cites W2794181547 @default.
- W3038438777 cites W2890927910 @default.
- W3038438777 cites W2904359944 @default.
- W3038438777 cites W2913409050 @default.
- W3038438777 cites W2913657690 @default.
- W3038438777 cites W2965078064 @default.
- W3038438777 cites W2968299957 @default.
- W3038438777 cites W2971737201 @default.
- W3038438777 cites W322580100 @default.
- W3038438777 cites W4241339381 @default.
- W3038438777 doi "https://doi.org/10.1248/cpb.c20-00017" @default.
- W3038438777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32611993" @default.
- W3038438777 hasPublicationYear "2020" @default.
- W3038438777 type Work @default.
- W3038438777 sameAs 3038438777 @default.
- W3038438777 citedByCount "18" @default.
- W3038438777 countsByYear W30384387772020 @default.
- W3038438777 countsByYear W30384387772021 @default.
- W3038438777 countsByYear W30384387772022 @default.
- W3038438777 countsByYear W30384387772023 @default.
- W3038438777 crossrefType "journal-article" @default.
- W3038438777 hasAuthorship W3038438777A5019544664 @default.
- W3038438777 hasAuthorship W3038438777A5036000781 @default.
- W3038438777 hasAuthorship W3038438777A5060619493 @default.
- W3038438777 hasAuthorship W3038438777A5069866009 @default.
- W3038438777 hasBestOaLocation W30384387771 @default.
- W3038438777 hasConcept C121608353 @default.
- W3038438777 hasConcept C126322002 @default.
- W3038438777 hasConcept C126511603 @default.
- W3038438777 hasConcept C178790620 @default.
- W3038438777 hasConcept C185592680 @default.
- W3038438777 hasConcept C2777783956 @default.
- W3038438777 hasConcept C2779820397 @default.
- W3038438777 hasConcept C2780035454 @default.
- W3038438777 hasConcept C2780192828 @default.
- W3038438777 hasConcept C502942594 @default.